Solexa Granted European Patent on use of Single Molecules for Sequencing
News Feb 02, 2006
Solexa, Inc. has announced that the European Patent Office has granted the company a key patent covering the use of single molecules for DNA analysis.
This granted patent, EP1105529B1, further strengthens Solexa’s intellectual property (IP) portfolio, which consists of some of the earliest and fundamental patents and applications addressing the use of both single molecules and amplified colonies of single molecules for genetic analysis applications, including DNA sequencing and gene expression analysis.
"The granting of this patent reinforces Solexa’s leadership position in the field of single molecule DNA analysis," stated John West, chief executive officer of Solexa.
"While today we are focused on commercializing our Clonal Single Molecule Array™ technology, our growing IP estate around the use of single molecules for DNA analysis provides us with the core technologies to develop and commercialize a system based on non-amplified single molecules."
"Additionally, we are positioned to protect our technology assets and to enter into strategic licensing in non-competitive fields."
EP1105529B1 covers devices comprising arrays of single molecules, including polynucleotides; methods for producing the devices; and their subsequent use.
An example would be in DNA sequencing and analysis. The patent claims cover any device where fluorophores are detected using optical microscopy by virtue of being attached to planar surfaces as single discrete entities.
Over 130 Glaucoma Gene Variants Could Help Predict BlindnessNews
An international study has identified 133 genetic variants that could help predict the risk of developing glaucoma, the world’s leading cause of incurable blindness. The findings are an advance in the fight to tackle the incurable, degenerative condition, which has virtually no symptoms in the early stages, and could lead to a genetic-based screening program.READ MORE
Yeast Study Performs Hundreds of Simultaneous CRISPR EditsNews
A new technique which can alter hundreds of different genes at once in baker's yeast could greatly speed up CRISPR-Cas9 editing and offer a way to perform high-throughput functional genomics.READ MORE
Cell Types Underlying Schizophrenia IdentifiedNews
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.READ MORE